文献速递功能神经外科

内侧伽玛刀丘脑毁损术治疗难治性疼痛

Medial Gamma Knife thalamotomy for intractable pain.
PubMed 文献 · J Neurosurg · 2018-01-01

该研究纳入1996年至2016年间接受单侧伽玛刀丘脑毁损术(GKT)的30例难治性重度疼痛综合征患者,中位年龄80岁、中位随访24个月。初始疼痛缓解成功13例(43.3%),其中1例完全缓解,中位起效潜伏期3个月;13例中4例(31%)在中位24个月后复发,未见神经功能缺损。

要点

  • 30例难治性疼痛患者接受单侧GKT,初始疼痛缓解率43.3%(13/30)。
  • 中位起效潜伏期3个月(范围2-12个月),13例中4例(31%)中位24个月后复发。
  • 研究未观察到神经功能缺损,作者认为GKT相对成功且安全。

核心结论

  • 作者认为,GKT对重度疼痛综合征患者是相对成功且安全的方法,即使对病情严重者也可使用;本研究唯一风险为治疗失败,因未观察到临床副作用。

研究设计与样本

  • 1996年至2016年间单侧GKT治疗30例保守治疗失败的重度疼痛综合征患者,女20例、男10例,中位年龄80岁(范围53-89岁),中位随访24个月(范围12-180个月)。

主要发现

  • 初始疼痛缓解成功13例(43.3%),其中1例完全缓解,中位起效潜伏期3个月(范围2-12个月)。
  • 13例中4例(31%)疼痛复发,中位潜伏间隔24个月(范围22-30个月)。
  • 未观察到神经功能缺损。

关键数值与推荐

  • 疼痛强度降至原水平50%以下视为成功。
  • 靶点为内侧丘脑的中央中核(CM)与束旁核(Pf)复合体,定位于第三脑室壁外侧4-6 mm、中点后方8 mm、连合间线上方2-3 mm。
  • 处方剂量145-150 Gy,单次照射,4 mm准直器。

临床怎么用

  • 原文未据此给出推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVEAblative procedures are still useful in the treatment of intractable pain despite the proliferation of neuromodulation techniques. In the paper the authors present the results of Gamma Knife thalamotomy (GKT) in various pain syndromes.METHODSBetween 1996 and 2016, unilateral GKT was performed in 30 patients suffering from various severe pain syndromes in whom conservative treatment had failed. There were 20 women and 10 men in the study population, with a median age of 80 years (range 53-89 years). The pain syndromes consisted of 8 patients with classic treatment-resistant trigeminal neuralgia (TN), 6 with postherpetic TN, 5 with TN and constant pain, 1 with TN related to multiple sclerosis, 3 with trigeminal neuropathic pain, 4 with thalamic pain, 1 with phantom pain, 1 with causalgic pain, and 1 with facial pain. The median follow-up period was 24 months (range 12-180 months). Invasive procedures for pain release preceded GKT in 20 patients (microvascular decompression, glycerol rhizotomy, balloon microcompression, Gamma Knife irradiation of the trigeminal root, and radiofrequency thermolesion). The Leksell stereotactic frame, GammaPlan software, and T1- and T2-weighted sequences acquired at 1.5 T were used for localization of the targeted medial thalamus, namely the centromedian (CM) and parafascicularis (Pf) nucleus. The CM/Pf complex was localized 4-6 mm lateral to the wall of the third ventricle, 8 mm posterior to the midpoint, and 2-3 mm superior to the intercommissural line. GKT was performed using the Leksell Gamma Knife with an applied dose ranging from 145 to 150 Gy, with a single shot, 4-mm collimator. Pain relief after radiation treatment was evaluated. Decreased pain intensity to less than 50% of the previous level was considered successful.RESULTSInitial successful results were achieved in 13 (43.3%) of the patients, with complete pain relief in 1 of these patients. Relief was achieved after a median latency of 3 months (range 2-12 months). Pain recurred in 4 (31%) of 13 patients after a median latent interval of 24 months (range 22-30 months). No neurological deficits were observed.CONCLUSIONSThese results suggest that GKT in patients suffering from severe pain syndromes is a relatively successful and safe method that can be used even in severely affected patients. The only risk of GT for the patients in this study was failure of treatment, as no clinical side effects were observed.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Urgosik D, Liscak R. Medial Gamma Knife thalamotomy for intractable pain. J Neurosurg. 2018. PMID: 30544296. doi:10.3171/2018.7.GKS181583

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。